I don't think there is a physiologic reason, I suspect it is for the same reason that CV outcomes have historically been less good for women than men--heart disease has tended to be overlooked and manifests somewhat differently in women, thus they often present with more advanced disease.
I feel like this trial is a little bit of a gimmick and also wouldn't provide any evidence for a sex differential obviously.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.